Adagene, Inc. (ADAG)
3.02
+0.09
(+3.07%)
USD |
NASDAQ |
Mar 05, 16:00
2.93
-0.09
(-2.98%)
After-Hours: 20:00
Adagene Cash from Investing (TTM) : 0.9077M for June 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -- |
| Zai Lab Ltd. | 308.68M |
| WuXi Biologics (Cayman), Inc. | -763.25M |
| Viva Biotech Holdings | -6.704M |